Genome-wide DNA methylation profiling was performed on a subset of the de novo RRD glioblastomas (n = 7) and a subset of the conventional IDH-wildtype glioblastomas (n = 98) to study their epigenomes. The gene discussed is IDH2; the disease is glioblastoma.